1 completed, 1 recruiting, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow REGN4461: new trials by email Literature Review of REGN4461 trials Research Report on REGN4461
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea Mibavademab, Placebo - Functional Hypothalamic Amenorrhea, FHA | Phase 2 | Recruiting | Regeneron Pharmaceuticals | 34 | 2026-03-11 | 2026-11-04 |
| A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity Tirzepatide, Mibavademab, Tirzepatide-Placebo - Obesity | Phase 2 | Completed | Eli Lilly and Company | 392 | 2024-04-24 | 2026-05-06 |
| A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) REGN4461, Matching Placebo - Familial Partial Lipodystrophy, Metabolic Abnormalities | Phase 2 | Terminated | Regeneron Pharmaceuticals | 20 | 2022-02-28 | 2025-10-16 |
Amenorrhea (1) · Infertility, Female (1) · Lipodystrophy, Familial Partial (1) · Obesity (1)
Regeneron Pharmaceuticals (2) · Eli Lilly and Company (1)
United States (3) · France (1) · Spain (1) · Turkey (Türkiye) (1)